Results 1 to 10 of about 20,060 (180)

Pegylated Interferon Lambda for Covid-19

New England Journal of Medicine, 2023
Mingqiang, Wang, Lingling, Tang, Lingtong, Huang   +2 more
openaire   +6 more sources

Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C

Journal of Nepal Medical Association, 2011
Until HCV NS3/4A protease inhibitors become available at the end of 2011, the combination pegylated-interferon (PEG-IFN)-alfa and ribavirin (RBV) will remain the standard treatment for chronic hepatitis C patients.
T Kanda, O Yokosuka
doaj   +1 more source

Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection

Kaohsiung Journal of Medical Sciences, 2017
Posttransplant hepatitis C virus (HCV) recurrence is universal in chronic hepatitis C recipients. Antiviral therapy is suggested after liver transplant to halt disease progression.
Ta-Ya Lin, Ming-Lun Yeh, Ching-I Huang, Yao-Li Chen, Chia-Yen Dai, Jee-Fu Huang, Zu-Yau Lin, Shinn-Cherng Chen, Chung-Feng Huang, Ming-Lung Yu, Wan-Long Chuang   +10 more
doaj   +1 more source

Microalbuminuria and pegylated interferon in hepatitis-c patients

Saudi Journal of Kidney Diseases and Transplantation, 2015
To determine the relation between hepatitis C virus (HCV) genotype 4 and microalbuminuria in relation to hepatic histology and viremia in the absence of cryoglobulinemia and to examine the effect of treatment on microalbuminuria, we studied 400 HCV genotype-4-infected patients who were tested for microalbuminuria, albumin creatinine ratio (ACR), urea ...
Yasser Elshahawi, Dawlat Sany, Walid Anwar Abd Elmohsen, Tarek Tantawi   +3 more
openaire   +3 more sources

PEG-INTERFERON ALPHA-2A AND LOW-DOSE RIBAVIRIN FOR TREATMENT OF HEPATITIS C VIRUS INFECTION IN PATIENTS WITH SICKLE CELL ANEMIA IN SAUDI ARABIA.

Mediterranean Journal of Hematology and Infectious Diseases, 2014
Introduction: Data regarding the safety and efficacy of antiviral therapy with pegylated interferon and ribavirin in patients with sickle cell disease and hepatitis C virus (HCV) infection are scanty.
Adnan Agha
doaj  

Clinical significance blood platelet count in patients with chronic hepatitis C on the background of the various options combined antiviral therapy

Журнал инфектологии, 2014
The purpose of this research is the study of the dynamics of platelet count in blood of patients with chronic hepatitis C on the background of the combined antiviral therapy with standard or pegylated interferon-α in combination with ribavirin.
K. V. Zhdanov, D. A. Gusev, K. V. Kozlov, A. V. Shekurov   +3 more
doaj   +1 more source

De novo Cryoglobulinaemic Mononeuritis Multiplex during Treatment of Chronic Hepatitis C Infection: A Viral Effect or Induced by Pegylated Interferon Alpha

Case Reports in Gastroenterology, 2012
Cryoglobulinaemic mononeuritis multiplex (MNM) is an extrahepatic manifestation of chronic hepatitis C virus (HCV) infection for which interferon-based antiviral therapy is currently the treatment of choice.
J.R. Potts, S. Atkinson, J.A. Aram, J. Tibble, K.A. Davies, S. Verma   +5 more
doaj   +1 more source

Some safety aspects of a new russian pegylated interferon-A medication “ALGERON” (phase 1 clinical trial)

RUDN Journal of Medicine, 2014
Treatment of hepatitis C is one of the most acute international healthcare problems. High standard in management of patients with HCV virus is combined therapy with pegylated interferon-a plus ribavirin.
A I Tukach, S B Fitilev, I I Shkrebniova, A V Vozzhaev, V A Yakushev, R A Ivanov, Yu N Lin’kova, T V Chernovskaya   +7 more
doaj  

Dilated cardiomyopathy and hypothyroidism associated with pegylated interferon and ribavirin treatment for chronic hepatitis C: case report and literature review

Brazilian Journal of Infectious Diseases, 2014
Pegylated interferon alpha (Peg IFN-α) in combination with ribavirin is the backbone of treatment in chronic hepatitis C (CHC). Cardiotoxicity due to interferon therapy is rare.
Wenxue Zhao, Fanpu Ji, Shanshan Yu, Zongfang Li, Hong Deng   +4 more
doaj   +1 more source

Test system for the detection of binding antibodies to interferon beta-1a for clinical use

Биопрепараты: Профилактика, диагностика, лечение, 2018
Test system for determining the presence of binding antibodies to interferon beta-1a (BAB to IFN beta-1a) in serum using ELISA has been developed.
E. A. Kuzminova, T. Yu. Ostroukhova, A. V. Grachev, E. L. Morozova   +3 more
doaj